Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: ValuEngine, Inc.
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Agenus Inc completes acquisition of 4-Antibody

Thursday, 13 Feb 2014 07:00am EST 

Agenus Inc:Completes the previously announced acquisition of 4-Antibody AG, a private European-based biopharmaceutical company.Agenus acquired all outstanding stock of 4-Antibody for about 3.3 million shares of Agenus common stock, plus additional contingent payments, payable in cash or Agenus common stock, that may exceed $40 million based on the combined company achieving certain milestones. 

Company Quote

-0.06 -0.72%
4:00pm EDT